Downloads: 3 | Views: 89 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Research Paper | Cancer Science | India | Volume 13 Issue 5, May 2024 | Popularity: 4.9 / 10

Rate This Article!      

Chimeric Antigen Receptors T Cells (CAR T) Therapy

Yuvraj Singh

Abstract: Chimeric antigen receptors T cells (CAR T) therapy represents a revolutionary approach to cancer treatment. Utilizing the power of immune system to target and eliminate malignant cells. The studies included were reviewed from PubMed, cancer. net, cancer. gov, clinical trials. gov, web of science. Through genetic engineering, T cells are modified to express chimeric antigen receptors, enabling them to recognize and attack specific antigens present on cancer cells. The positive result of CAR - T therapy in treating hematologic malignancies, such as ALL acute lymphoblastic leukemia and non - Hodgkin lymphoma, has been remarkable. However, complications remain, including the management of CAR - T cell infusion - related effects such as cytokine release syndrome and neurotoxicity, as well as the growth of resistance mechanisms in some cases.

Keywords: chimeric antigen receptor T cell, response, side effect, relapse, analysis

Edition: Volume 13 Issue 5, May 2024

Pages: 1563 - 1566

DOI: https://www.doi.org/10.21275/SR24523173932

Make Sure to Disable the Pop-Up Blocker of Web Browser

Click to Cite this Article

Similar Articles